Treatment of Autoimmune Hypophysitis
The cornerstone of treatment for autoimmune hypophysitis is hormone replacement therapy for all patients, with glucocorticoids reserved for those with significant mass effects (severe headaches, visual changes, or optic chiasm compression), while endocrinology consultation should be obtained immediately for all cases. 1
Initial Management Algorithm
All Grades - Universal Requirements
- Immediate endocrinology referral 1
- Patient education on:
- Stress dosing protocols for illness/surgery
- Emergency injectable glucocorticoids
- Medical alert bracelet/necklace for adrenal insufficiency 1
Grade 1 (Asymptomatic or Mild Symptoms)
Hormone replacement only - no high-dose glucocorticoids needed 1
Start hydrocortisone 15-20 mg daily in divided doses (typically 2/3 morning, 1/3 early afternoon) 1
- Critical: Always start corticosteroid replacement BEFORE thyroid hormone to avoid precipitating adrenal crisis 2
Add thyroid hormone replacement if needed:
- Goal: Free T4 in upper half of reference range
- TSH is unreliable in central hypothyroidism 1
Consider testosterone/estrogen replacement if deficient and no contraindications (prostate cancer, breast cancer, DVT history) 1
Can continue immunotherapy once stabilized on replacement hormones 1
Grade 2 (Moderate Symptoms, Able to Perform ADLs)
Consider holding immunotherapy until hormonal stabilization 1
- Hormone replacement as in Grade 1
- Add oral pulse-dose glucocorticoids ONLY if:
- MRI shows pituitary swelling
- Threatened optic chiasm compression
- Dose: Prednisone 1 mg/kg/day 1
- Taper over 1-2 weeks to physiologic maintenance (5 mg prednisone equivalent)
Grade 3-4 (Severe Symptoms, Unable to Perform ADLs)
Hold immunotherapy and hospitalize 1
IV fluid resuscitation: At least 2L normal saline 1
IV stress-dose steroids: Hydrocortisone 50-100 mg every 6-8 hours 1
- Taper to oral maintenance over 5-7 days
Oral pulse-dose therapy if:
- Significant pituitary swelling on MRI
- Optic chiasm compression
- Severe headache or visual changes
- Dose: Prednisone 1-2 mg/kg/day, taper over 1-2 weeks 1
Maintenance hormone replacement as in Grade 1
Diagnostic Workup (Morning Testing Preferred)
Essential labs (ideally at 8 AM): 2
- ACTH and cortisol
- TSH and free T4
- Electrolytes
- In males: LH and testosterone
- In premenopausal females: FSH and estrogen
Consider ACTH stimulation testing if morning cortisol 3-15 mg/dL 1
MRI brain with pituitary cuts for all patients with: 1, 2
- New hormonal deficiencies
- Multiple endocrine abnormalities
- Severe headaches
- Visual changes
- Mandatory for diabetes insipidus (most commonly from metastatic disease)
Critical Pitfalls to Avoid
Never start thyroid hormone before glucocorticoid replacement - this can precipitate life-threatening adrenal crisis 2
ACTH stimulation can be falsely negative early in hypophysitis - adrenal reserve declines slowly after pituitary stimulation is lost. When uncertain, opt for replacement and retest at 3 months 1
Hydrocortisone 20 mg = Prednisone 5 mg - use this conversion when switching 1
Lower glucocorticoid doses are preferred when treating for symptoms (average 7.5 mg daily over 2 months) due to reports of reduced survival with higher doses 1
TSH remains unreliable in central hypothyroidism - use free T4 to guide thyroid replacement, targeting upper half of reference range 1
Refractory or Recurrent Disease
For post-glucocorticoid persistent or recurrent primary autoimmune hypophysitis, non-glucocorticoid immunosuppressive therapy (NGIT) is effective 3:
- Rituximab shows best radiological response (100%) 3, 4
- Azathioprine is most commonly used single agent 3
- Mycophenolate mofetil shows ~66% radiological response 3
- Adverse events occur in ~20% (hepatitis, leucopenia, alopecia) 3
Rituximab is particularly effective for B-cell predominant hypophysitis and may achieve sustained remission even after discontinuation 4
Long-Term Prognosis
Both adrenal insufficiency and hypothyroidism are typically permanent - lifelong hormone replacement is required in most cases 2. Only 15-18% of patients achieve full pituitary function recovery 5. Panhypopituitarism (adrenal insufficiency + hypothyroidism + hypogonadism) occurs in approximately 50% of patients 2.